Drug "Lerivon". tohutohu mo tona whakamahi.

"Lerivon" - he tarukino e pā ana ki pōuritanga. I roto i te tikanga ki te taea ki te kia maheni ki te hanganga me te o ona wāhanga e piri tonu ki te tarukino "Lerivon" ako.

Ko te hanganga o "lerivon" Ko te taonga hohe tarukino - hydrochloride mianserin (30 mg), me kai pŭpŭ tauturu: konupora stearate, māngaro potato, meliltsellyuloza, kalloidny silica anhydrous, konupūmā Phosphate, Titanium hāorarua (E 171), macrogol, hypromellose.

pā ana te taonga mianserin kaha ki te pūhui piperazino-azepine e e matū e pā ana ki pōuritanga tricyclic. "Lerivon" āraia alpha2 receptor me inhibits reuptake o norepinephrine, reira te whakanui ake i te tuku noradrenergic roro. tāutuhia hoki tatou pāhekoheko serotinovymi ki receptors i roto i te pūnaha io pokapū. Te raau hoki he pānga anxiolytic, i te mea tino nui i roto i te maimoatanga o disorders manukanuka me disorders moe, e kua meinga e te kāwanatanga te tumatatenga whānui o te tangata.

Āpitihia ki te tarukino "Lerivon" tohu tauākī e te pai noatia te tarukino e tūroro ki mate o te pūnaha Cardiovascular, me te te kau ta'umotu'á. I pota e te hunga therapeutically whai hua "Lerivon" kua tata kore pānga i runga i te pūnaha Cardiovascular. e kore te mea moku, ki te mahi anticholinergic ia. He pānga iti cardiotoxic i roto i te tuwhena rawa atu pōuritanga tritseklicheskie. e kore e "Lerivon" tirohia ki te te raveraa ra antihypertensive me āpiha sympathomimetic.

tarukino whakamahia "Lerivon 'i te depressions o ngā etiologies. Heoi, i reira he torutoru contraindications. I roto i te tikanga ki te waia kiritaki ki a ratou piri ki te tarukino "Lerivon" ako. Pānuitia te reira i roto i te taipitopito, ka taea e kite koe i e he e taea ki te farii i "Lerivon": i roto i te take o te hypersensitivity ki te taonga hohe - mianserin tetahi wāhanga turuki ranei; tamariki me ngā taiohi o muri atu i te 18 tau; i roto i mate o te ate, me ofatiraa nui o ona mahi.

Whakatūpatotanga ki te tango i tenei utu tarukino hoki te iwi ki te tākihi ate ranei kore, kore ngakau ma'i, koki-katinga papahewa, mate huka, hypertrophy prostatic. Na i runga i te wā o te hapū me te hohipera, kua piri ki te tarukino taea "Lerivon" ako ki a koutou te ako ngā mōhiohio e whakahaeretia ngā i runga i te kararehe, me te kohia i roto i te faatura o te tangata, iti raraunga. I tenei kaupapa, i kitea ai e mianserin kua kahore neontalnogo kino intrauterine ranei. I kitea ano hoki te reira i taua mianserin whenumi i roto i te waiu uma i roto i moni iti. Heoi, ahakoa tenei i mua i te hanga "Lerivon" ka kai hapū ranei, me whakarite e koe te painga o te tarukino me te tūpono ki te kukune me te tamaiti.

Ka taea e koe te pānui i pā ana ki te rongoa hua "Lerivon" arotake i mua i te whakamahi tika o te tarukino. Mai i te arotake e taea ētahi wā tiki koe ngā mōhiohio whai hua. Hei tauira, ka taea e koe te ako e pā ana ki etahi o nga pānga taha: rawa maha somnolence; ētahi wā nui haere taimaha tinana; whakaahuatia rite wā tino onge o agranulocytosis, whanaketanga leukopenia reversible, cramps, arthralgia, gynecomastia, edema, ino o te ate mahi.

Āpitihia ki te tarukino "kore te Lerivon 'tohutohu mō te whakamahi tikanga mō ngā take whaiaro maimoatanga-a mo te tohutoro anake. He mea tika ki te tango i tenei ki pūkete te aroaro o te whakamahi tarukino. Treatment whakaritea e te tākuta.